{"entity":{"id":"nct06760819","kind":"trial","name":"A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)","aka":["panSOHO"],"tldr":"A phase 2 trial of BAY2927088 in advanced solid tumours, run by Bayer, now recruiting.","summary":"A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2) is a phase 2 interventional study registered as NCT06760819 by Bayer, with 111 participants planned, started 2025-02-13 and due to reach its primary completion in 2029-02-02. Interventions recorded: BAY2927088.","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT06760819","url":"https://clinicaltrials.gov/study/NCT06760819"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["metastatic-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":["bayer"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT06760819","phase":"2","setting":"A Phase 2 Open-label Basket Study to Evaluate the Efficacy and Safety of Orally Administered Reversible Tyrosine Kinase Inhibitor BAY 2927088 in Participants With Metastatic or Unresectable Solid Tumors With HER2-activating Mutations","sponsor":"Bayer","participation":[{"nct":"NCT06760819","source":"https://clinicaltrials.gov/study/NCT06760819","fetchedAt":"2026-10-07T16:55:00.061Z","studySha256":"7047cab24fcf4d9931bcca7d888dc0115a883a523e5f9de3157b28f1b9b642cc","overallStatus":"RECRUITING","lastUpdatePosted":"2026-10-02","leadSponsor":"Bayer","collaboratorCount":0,"minimumAge":"18 Years","sex":"ALL","healthyVolunteers":false,"hasEligibility":true,"enrolment":111,"enrolmentType":"ESTIMATED","siteCount":54,"recruitingSiteCount":34,"countries":["Australia","Canada","China","Denmark","France","Italy","Japan","South Korea","Spain","Switzerland","United States"]}],"started":"2025-02-13","startedType":"actual","enrolled":111,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct06760819/","neighbours":{"cancer":[{"id":"metastatic-cancer","kind":"cancer","name":"Metastatic cancer (cancer that has spread)","route":"/cancers/metastatic-cancer/"}],"company":[{"id":"bayer","kind":"company","name":"Bayer","route":"/companies/bayer/"}]}}